WA
ANIP icon

WFG Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

WFG Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,000
Closed -$28K – 2079
2014
Q3 		$28K Sell
1,000
-1,400
-58% -$42K 0.01% 1146
2014
Q2 		$83K Buy
+2,400
New +$75.3K 0.02% 721
2014
Q1 		– Sell
-1,000
Closed -$20K – 1989
2013
Q4 		$20K Hold
1,000
– – ﹤0.01% 1340
2013
Q3 		$10K Buy
1,000
+972
+3,471% +$7K ﹤0.01% 1506
2013
Q2 		$0 Buy
+28
New +$196 ﹤0.01% 2078

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

WFG Advisors's ANIP Position: Q4 2014 in Review

WFG Advisors sold out of ANI Pharmaceuticals (ANIP) in Q4 2014, closing a stake of 1,000 shares — an estimated $28K sold.

WFG Advisors first reported a position in ANIP in Q2 2013 and held it in 5 quarters. The position peaked at $83K in Q2 2014. 101 funds tracked by Wall St. Rank hold ANIP as of Q4 2014.

  • WFG Advisors reported no remaining ANI Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • WFG Advisors sold 1,000 ANI Pharmaceuticals shares in Q4 2014, an estimated $28K.
  • WFG Advisors first reported a position in ANI Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • WFG Advisors's ANI Pharmaceuticals position peaked at $83K in Q2 2014.
  • 101 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2014.

Based on WFG Advisors's 13F filing for Q4 2014, filed 12 Feb 2015.